Benign Prostatic Hyperplasia Treatment
APAC · 2 shared keywords
APAC ENT Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
APAC · 2024–2034 · estimates
Market Dashboard
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Estimate 2024
$5.22 Bn
Estimated value
Estimate 2025
$5.59 Bn
19.3% of the global market
Projected 2034
$10.27 Bn 83.8%
Adds $4.68 Bn over 9 forecast years
CAGR 2025–2034
7.0%
Faster than 9% of 173 Medical Devices markets here
Key players
5
- APAC is 19.3% of the global market.
- Among regions, the largest is North America at $15.26 Bn.
- Fastest growing: Africa at 7.4% a year.
- APAC ranks 3rd of 6 by size among regions.
Market size projection
APACSource: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
Value added each year
$4.68 Bn total, 2026–2034
Year-by-year market size, 2024–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $5.22 Bn | — | — |
| 2025 (base) | $5.59 Bn | +$365.5 Mn | — |
| 2026 (forecast) | $5.98 Bn | +$391.0 Mn | +7% |
| 2027 (forecast) | $6.40 Bn | +$418.4 Mn | +14.5% |
| 2028 (forecast) | $6.84 Bn | +$447.7 Mn | +22.5% |
| 2029 (forecast) | $7.32 Bn | +$479.0 Mn | +31.1% |
| 2030 (forecast) | $7.84 Bn | +$512.6 Mn | +40.3% |
| 2031 (forecast) | $8.38 Bn | +$548.5 Mn | +50.1% |
| 2032 (forecast) | $8.97 Bn | +$586.8 Mn | +60.6% |
| 2033 (forecast) | $9.60 Bn | +$627.9 Mn | +71.8% |
| 2034 (forecast) | $10.27 Bn | +$671.9 Mn | +83.8% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Same market worldwide
By geography
- Global $28.94 Bn
- North America $15.26 Bn
-
US
$10.77 Bn
- Europe $6.15 Bn
- APAC (this report) $5.59 Bn
-
Canada
$2.10 Bn
-
China
$2.10 Bn
-
Japan
$1.58 Bn
- Latin America $1.30 Bn
- Middle East $1.22 Bn
-
Germany
$952.6 Mn
-
France
$786.8 Mn
-
UK
$720.6 Mn
-
Brazil
$698.5 Mn
-
Spain
$615.7 Mn
-
Ecuador
$623.1 Mn
-
Italy
$585.4 Mn
-
India
$557.1 Mn
-
Saudi Arabia
$493.0 Mn
-
Mexico
$441.9 Mn
- Africa $439.2 Mn
-
Australia
$392.8 Mn
-
New Zealand
$288.8 Mn
-
Russia
$281.9 Mn
-
South Africa
$194.6 Mn
-
UAE
$126.9 Mn
-
Egypt
$87.1 Mn
-
Philippines
$66.3 Mn
-
Hong Kong
$53.8 Mn
-
Malaysia
$42.3 Mn
-
Singapore
$39.9 Mn
-
Thailand
$34.1 Mn
-
Kenya
$19.0 Mn
The APAC ENT Devices Market Analysis Executive Summary
ENT devices diagnose and treat ear, nose and throat problems, from scopes and balloons to hearing implants.
Key segments of the ENT Devices market include product (Diagnostic Scopes, Balloon Sinus Dilation and Powered Surgical Instruments) and setting (Hospitals, ENT Clinics and Ambulatory Surgery Centers).
APAC ENT Devices Market Dynamics
Market Growth Drivers
Rising rates of sleep apnea, sinus disease and hearing loss, an ageing population and less invasive treatments are driving the ENT Devices market.
Opportunity
Home-based diagnosis, smaller connected devices and office-based procedures give the ENT Devices market room to grow.
Market Restraints
Device costs, patients stopping therapy, limited reimbursement and supply issues after recalls hold back the ENT Devices market.
Competitive Landscape for ENT Devices Market in APAC
The ENT Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Key Players
Healthcare Policies and Regulatory Landscape for ENT Devices Market in APAC
Policy changes and Reimbursement scenario
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how ENT Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in ENT Devices right now, from free public sources.
Latest research 357 papers since 2021 (worldwide)
- Artificial intelligence in Saudi otolaryngology research: a scoping review of the current landscape, gaps, and future directions. Frontiers in surgery, 2026
- Ruptured INfrarenal abdominal AneurySm: aortiC repair using the ENduranT Endograft. The R.IN.AS.C.ENT.E. Study. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2026
- [Sleep Medicine in ENT Practice - An Overview of Diagnosis and Current Treatment]. Laryngo- rhino- otologie, 2026
- Expert assessment of medical and organizational care for children with congenital ear malformations in the Republic of Kazakhstan: The RAND/UCLA appropriateness method. American journal of otolaryngology, 2026
- Machine Learning for Non-invasive Differentiation of Glottic Carcinoma Versus Laryngeal Immobility. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2026
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
ENT Devices in context
Questions, answered with public data
- How much research is published on ENT Devices?
- PubMed lists 357 papers added since January 2021 that match this market, worldwide.[1]
[1] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Free data on this topic
From our blog
Ambulatory Surgery Centres: Same-Day Surgery GrowsMore than 300 million operations are done each year, and many no longer need an overnight stay. Ambulatory…
Energy-Based Surgical Devices: Precision in the ORMore than 300 million operations are performed each year. Energy-based devices that cut and seal tissue with…
Single-Use Surgical Devices: Safety vs WasteSingle-use devices cut infection risk, but about 15% of health-care waste is hazardous. Hospitals are trying…